Raritan Pharmaceuticals Inc.
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Raritan Pharmaceuticals Inc. is a pharmaceuticals company based out of 8 Joanna Ct, East Brunswick, NJ, United States.
Market Positioning Raritan Pharmaceuticals operates in the competitive pharmaceutical manufacturing sector with an estimated revenue between 50 million and 100 million dollars, indicating growth potential and opportunities for expanding distribution channels and collaborations.
Technology Stack The company leverages various advanced web technologies such as WordPress, MySQL, and Microsoft ASP.NET, suggesting potential needs for software solutions, IT infrastructure enhancements, or digital marketing support.
Employee Scale With a team of 51 to 200 employees, Raritan Pharmaceuticals may benefit from targeted HR and operational tools, and has the capacity for scalable partnerships or service integrations to support future expansion.
Industry Trends Given its proximity in revenue to major players like Hikma and Glenmark, Raritan Pharmaceuticals is positioned to capitalize on industry shifts such as rising R&D investments, generics expansion, and healthcare market growth.
Growth Opportunities The company's relatively modest size and financial growth suggest potential for product innovation, licensing opportunities, or strategic partnerships with larger firms aiming to diversify their portfolios.
Raritan Pharmaceuticals Inc. uses 8 technology products and services including WordPress, MySQL, Font Awesome, and more. Explore Raritan Pharmaceuticals Inc.'s tech stack below.
| Raritan Pharmaceuticals Inc. Email Formats | Percentage |
| FLast@raritanpharm.com | 85% |
| First@raritanpharm.com | 10% |
| First.Last@raritanpharm.com | 3% |
| FirstMiddle.Last@raritanpharm.com | 2% |
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Raritan Pharmaceuticals Inc. is a pharmaceuticals company based out of 8 Joanna Ct, East Brunswick, NJ, United States.
Raritan Pharmaceuticals Inc.'s revenue is estimated to be in the range of $50M$100M
Raritan Pharmaceuticals Inc.'s revenue is estimated to be in the range of $50M$100M